ClearPoint Neuro (CLPT) EBT Margin (2011 - 2026)
ClearPoint Neuro (CLPT) posted EBT Margin of 78.69% for Q1 2026, down 5.27% sequentially from 74.76% in Q4 2025, and down 789.0% YoY from 11.42% in Q1 2025.
ClearPoint Neuro (CLPT) EBT Margin (2011 - 2026) Analysis & Trends
ClearPoint Neuro has reported EBT Margin for 15 years, with the latest figure at 78.69% in Q1 2026.
- Quarterly EBT Margin fell 789.0% year-over-year to 78.69% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 71.46% (down 700.0% YoY) and the FY2025 annual result came in at 68.93%, down 872.0% from the prior year.
- EBT Margin eased to 78.69% in Q1 2026 per CLPT's latest filing, from 74.76% in the prior quarter.
- Over five years, EBT Margin peaked at 54.08% in Q1 2024 and troughed at 282.37% in Q2 2022.
- A 5-year average of 116.96% and a median of 74.76% in 2025 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2022 and 2025: EBT Margin soared 36216 bps in 2022, then plunged 1673 bps in 2025.
- Over 5 years, EBT Margin stood at 89.7% in 2022, then advanced by 20 bps to 71.88% in 2023, then rose by 3 bps to 69.72% in 2024, then declined by 7 bps to 74.76% in 2025, then fell by 5 bps to 78.69% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 78.69%, 74.76%, and 66.39% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 18.32% |
| 10 | ClearPoint Neuro | 468.94 Mn | 439.54 Mn | 6.71 Mn | -104.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -104.55% |
| Mar 31, 2026 | -78.69% |
| Dec 31, 2025 | -74.76% |
| Sep 30, 2025 | -66.39% |
| Jun 30, 2025 | -63.07% |
| Mar 31, 2025 | -70.81% |
| Dec 31, 2024 | -69.72% |
| Sep 30, 2024 | -61.07% |
| Jun 30, 2024 | -55.90% |
| Mar 31, 2024 | -54.08% |
| Dec 31, 2023 | -71.88% |
| Sep 30, 2023 | -117.39% |
| Jun 30, 2023 | -188.71% |
| Mar 31, 2023 | -203.35% |
| Dec 31, 2022 | -89.70% |
| Sep 30, 2022 | -214.65% |
| Jun 30, 2022 | -282.37% |
| Mar 31, 2022 | -225.86% |
| Dec 31, 2021 | -104.16% |
| Sep 30, 2021 | -418.28% |